Radiopaque amino-functional crosslinking agents for medical applications

Patent metadata

Field	Value
Publication number	US-2025295816-A1
Application number	US-202519084378-A
Country	US
Kind code	A1
Filing date	Mar 19, 2025
Priority date	Mar 20, 2024
Publication date	Sep 25, 2025
Grant date	—

Abstract

In some aspects, the present disclosure pertains to systems for forming hydrogels that comprise (a) a radiopaque polyamino compound and (b) a reactive polymer comprising a plurality of hydrophilic polymer segments and a plurality of reactive moieties, wherein the reactive moieties are reactive with amino groups of the radiopaque polyamino compound, and wherein the radiopaque polyamino compound is produced by a method that comprises: (i) converting hydroxyl groups of a polyhydroxylated radiopaque compound to amino groups, (ii) converting vicinal diol groups (—CHOHCH 2 OH groups) of a polyhydroxylated radiopaque compound into hydroxyaminoethyl groups (—CHOHCH 2 NH 2 groups), or (iii) converting vicinal diol groups of a polyhydroxylated radiopaque compound into aminomethyl groups (—CH 2 NH 2 groups). In other aspects, the present disclosure pertains to hydrogels formed from such systems and to methods of treatment using such systems.

First claim

1 . A system for forming a hydrogel that comprises (a) a radiopaque polyamino compound and (b) a reactive polymer comprising a plurality of hydrophilic polymer segments and a plurality of reactive moieties, wherein the reactive moieties are reactive with amino groups of the radiopaque polyamino compound, and wherein the radiopaque polyamino compound is produced by a method that comprises: (i) converting hydroxyl groups of a polyhydroxylated radiopaque compound to amino groups, (ii) converting vicinal diol groups (—CHOHCH 2 OH groups) of a polyhydroxylated radiopaque compound into hydroxyaminoethyl groups (—CHOHCH 2 NH 2 groups), or (iii) converting vicinal diol groups of a polyhydroxylated radiopaque compound into aminomethyl groups (—CH 2 NH 2 groups).

2 . The system of claim 1 , wherein the polyhydroxylated radiopaque compound comprises at least one hydroxy-substituted iodinated aromatic group.

3 . The system of claim 2 , wherein the at least one hydroxy-substituted iodinated aromatic group comprises a monocyclic or multicyclic aromatic group that is substituted with a plurality of iodine groups and a plurality of hydroxyalkyl-containing groups.

4 . The system of claim 3 , wherein the plurality of hydroxyalkyl-containing groups comprises C 2 -C 6 -hydroxyalkyl groups.

5 . The system of claim 4 , wherein the C 2 -C 6 -hydroxyalkyl groups comprise at least one vicinal diol group.

6 . The system of claim 3 , wherein the plurality of hydroxyalkyl-containing groups comprises at least one hydroxyalkyl-containing group that is linked to the monocyclic or multicyclic aromatic group through an amide-containing linkage.

7 . The system of claim 1 , wherein the polyhydroxylated radiopaque compound is selected from iopromide, iopamidol, iomeprol, ioversol, iobitridol, iotrolan, iodixanol, [3,5-bis(hydroxymethyl)-2,4,6-triiodo-phenyl]methanol, 1 2,3,5,6-tetraiodo-1,4-benzenedimethanol, and 1-[2,4,6-triiodo-3,5-bis(1,2,3-trihydroxypropyl)phenyl]propane-1,2,3-triol.

8 . The system of claim 1 , wherein the radiopaque polyamino compound comprises at least one amino-substituted iodinated aromatic group.

9 . The system of claim 8 , wherein the at least one amino-substituted iodinated aromatic group comprises a monocyclic or multicyclic aromatic group that is substituted with a plurality of iodine groups and a plurality of amino-containing groups.

10 . The system of claim 9 , wherein the plurality of amino-containing groups comprises aminoalkyl groups that comprise one or more amino groups and one or more carbon atoms.

11 . The system of claim 10 , wherein the aminoalkyl groups comprise at least one C 2 -C 6 -aminoalkyl group that comprises two amino groups positioned on adjacent carbon atoms and/or or wherein the aminoalkyl groups comprises at least one C 2 -C 6 -aminoalkyl group that comprises a single terminal amino group.

12 . The system of claim 9 , wherein the plurality of amino-containing groups comprises at least one hydroxyaminoalkyl group that comprises one or more amino groups, one or more hydroxyl groups and one or more carbon atoms.

13 . The system of claim 12 , wherein the at least one hydroxyaminoalkyl group comprises at least one C 2 -C 6 -hydroxyaminoalkyl group that comprises a hydroxyl group and an amino group positioned on adjacent carbon atoms.

14 . The system of claim 9 , wherein the plurality of amino-containing groups comprises at least one amino-containing group that is linked to the monocyclic or multicyclic aromatic group through an amide-containing linkage.

15 . The system of claim 1 , wherein the reactive polymer is a multi-arm polymer that comprises three or more polymer arms linked to a core region, each arm comprising one of the hydrophilic polymer segments and one of the reactive moieties that are reactive with the amino groups of the radiopaque polyamino compound to form covalent crosslinks.

16 . The system of claim 15 , wherein the core region comprises a polyol residue and/or wherein the hydrophilic polymer segments are selected from polyalkylene oxide segments, polyester segments, polyoxazoline segments, polydioxanone segments, and polypeptide segments.

17 . The system of claim 1 , comprising a first composition that comprises the radiopaque polyamino compound in a first container and a second composition that comprises the reactive polymer in a second container, wherein the first container and the second container are independently selected from vials and syringe barrels.

18 . The system of claim 17 , wherein the first container is a syringe barrel, and the second container is a vial.

19 . A crosslinked radiopaque hydrogel produced by system that comprises (a) a radiopaque polyamino compound and (b) a reactive polymer comprising a plurality of hydrophilic polymer segments and a plurality of reactive moieties, wherein the reactive moieties are reactive with amino groups of the radiopaque polyamino compound, and wherein the radiopaque polyamino compound is produced by a method that comprises: (i) converting hydroxyl groups of a polyhydroxylated radiopaque compound to amino groups, (ii) converting vicinal diol groups (—CHOHCH 2 OH groups) of a polyhydroxylated radiopaque compound into hydroxyaminoethyl groups (—CHOHCH 2 NH 2 groups), or (iii) converting vicinal diol groups of a polyhydroxylated radiopaque compound into aminomethyl groups (—CH 2 NH 2 groups).

20 . A method of treatment comprising administering to a subject a mixture that comprises (a) a radiopaque polyamino compound and (b) a reactive polymer comprising a plurality of hydrophilic polymer segments and a plurality of reactive moieties, wherein the reactive moieties are reactive with amino groups of the radiopaque polyamino compound, and wherein the radiopaque polyamino compound is produced by a method that comprises: (i) converting hydroxyl groups of a polyhydroxylated radiopaque compound to amino groups, (ii) converting vicinal diol groups (—CHOHCH 2 OH groups) of a polyhydroxylated radiopaque compound into hydroxyaminoethyl groups (—CHOHCH 2 NH 2 groups), or (iii) converting vicinal diol groups of a polyhydroxylated radiopaque compound into aminomethyl groups (—CH 2 NH 2 groups), wherein the mixture is administered under conditions such that the amino groups of the radiopaque polyamino compound and the reactive moieties of the reactive polymer form covalent crosslinks after administration.

Assignees

• Boston Scient Scimed Inc

Inventors

• Hsu Yen-Hao
• Cirka Heather
• Ball-Jones Nicolas
• Dorn Rick
• Delaney Jr Joseph Thomas
• Parisi Cristian

Classifications

• A61L2430/36

  for embolization or occlusion, e.g. vaso-occlusive compositions or devices · CPC title

• A61L24/046

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence) · CPC title

• A61L24/0015

  Medicaments; Biocides · CPC title

• A61L24/0031

  Hydrogels or hydrocolloids · CPC title

• A61L27/16

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title